We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+11.77%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.8B
AUM Growth
-$40.1M
Cap. Flow
-$460M
Cap. Flow %
-7.92%
Top 10 Hldgs %
24.55%
Holding
197
New
37
Increased
72
Reduced
55
Closed
17

Top Sells

Rank Stock Value
1
TMDX icon
Transmedics
TMDX
+$70.1M
2
TT icon
Trane Technologies
TT
+$69.4M
3
DDOG icon
Datadog
DDOG
+$63.8M
4
ARGX icon
argenx
ARGX
+$56M
5
GTLB icon
GitLab
GTLB
+$46.9M

Sector Composition

Rank Sector Weight
1 Healthcare 40.6%
2 Technology 18.78%
3 Industrials 17.39%
4 Consumer Discretionary 9.97%
5 Financials 2.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SHW icon
51
Sherwin-Williams
SHW
$83.7B
$37.7M 0.65%
98,770
+925
+0.9% +$323K
CRNX icon
52
Crinetics Pharmaceuticals
CRNX
$8.85B
$37.6M 0.65%
735,088
PWR icon
53
Quanta Services
PWR
$98.7B
$37.6M 0.65%
125,966
+59
+0% +$15.6K
CPRT icon
54
Copart
CPRT
$27.4B
$37.4M 0.64%
714,080
+526
+0.1% +$27.3K
ISRG icon
55
Intuitive Surgical
ISRG
$126B
$37M 0.64%
75,358
+83
+0.1% +$38.6K
LSCC icon
56
Lattice Semiconductor
LSCC
$17.7B
$36.9M 0.64%
695,002
+138,104
+25% +$7.07M
EGP icon
57
EastGroup Properties
EGP
$11.3B
$35.2M 0.61%
188,661
+31,790
+20% +$5.86M
STE icon
58
Steris
STE
$22.5B
$34.8M 0.6%
143,459
+11,362
+9% +$2.66M
AVB icon
59
AvalonBay Communities
AVB
$26.8B
$34.3M 0.59%
152,408
+33,230
+28% +$7.18M
SRPT icon
60
Sarepta Therapeutics
SRPT
$1.64B
$34.1M 0.59%
272,954
+44,425
+19% +$6.14M
PANW icon
61
Palo Alto Networks
PANW
$265B
$34M 0.59%
199,236
-230,710
-54% -$38.8M
BPMC
62
DELISTED
Blueprint Medicines
BPMC
$32.3M 0.56%
348,704
+117,019
+51% +$11.6M
GERN icon
63
Geron
GERN
$860M
$32.1M 0.55%
7,072,000
+715,818
+11% +$3.25M
ZNTL icon
64
Zentalis Pharmaceuticals
ZNTL
$350M
$31.5M 0.54%
8,547,896
FLYW icon
65
Flywire
FLYW
$2.01B
$29M 0.5%
1,767,625
-1,304,806
-42% -$22.8M
VKTX icon
66
Viking Therapeutics
VKTX
$3.84B
$28.7M 0.49%
452,969
+200,000
+79% +$11.7M
HLI icon
67
Houlihan Lokey
HLI
$8.97B
$26.7M 0.46%
168,910
-65,970
-28% -$9.86M
INSP icon
68
Inspire Medical Systems
INSP
$1.44B
$26.4M 0.46%
125,090
WDAY icon
69
Workday
WDAY
$39B
$26.3M 0.45%
107,510
+10,723
+11% +$2.53M
PNR icon
70
Pentair
PNR
$10.6B
$26.2M 0.45%
267,538
-50,581
-16% -$4.33M
NARI
71
DELISTED
Inari Medical, Inc. Common Stock
NARI
$25.6M 0.44%
619,649
ALV icon
72
Autoliv
ALV
$9.09B
$24.9M 0.43%
266,854
-11,622
-4% -$1.16M
PEG icon
73
Public Service Enterprise Group
PEG
$38.6B
$24.7M 0.43%
276,734
-9,562
-3% -$763K
UTHR icon
74
United Therapeutics
UTHR
$26.2B
$24.3M 0.42%
67,825
KYMR icon
75
Kymera Therapeutics
KYMR
$8.8B
$24M 0.41%
507,902
+45,803
+10% +$2.02M

Similar funds

Eventide Asset Management's Q3 2024 Portfolio in Review

As of Q3 2024, Eventide Asset Management held 197 positions worth $5.8B, down 0.69% from $5.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management withdrew a net $460M in Q3 2024, closing 17 positions and reducing 55 holdings. Its most notable exit was Nextpower Inc, an estimated $36.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 38% a quarter earlier, followed by Technology and Industrials.

Against the trend, Eventide Asset Management opened a new position in Relay Therapeutics worth $19M.

  • Eventide Asset Management's largest Q3 2024 buy was Relay Therapeutics: 2,682,083 shares worth $19M.
  • Eventide Asset Management added most to Verona Pharma in Q3 2024, an estimated $46.7M increase.
  • Eventide Asset Management's biggest Q3 2024 reduction was Transmedics, cutting an estimated $70.1M.
  • Eventide Asset Management fully exited Nextpower Inc in Q3 2024, selling an estimated $36.6M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.8B portfolio in Q3 2024.
  • Eventide Asset Management opened 37 new positions and closed 17 in Q3 2024.
  • Eventide Asset Management's portfolio value fell 0.69% quarter-over-quarter to $5.8B.

Based on Eventide Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.